open access

Vol 21, No 4 (2014)
Original articles
Published online: 2014-08-29
Get Citation

Impact of pulmonary vein isolation on obstructive sleep apnea in patients with atrial fibrillation

Friedrich Felix Hoyer, Katharina Henrich, Jens Kreuz, Carmen Pizarro, Jan-Wilko Schrickel, Lars Martin Lickfett, Erica Mittmann-Braun, Uwe Juergens, Georg Nickenig, Dirk Skowasch
DOI: 10.5603/CJ.a2013.0122
·
Cardiol J 2014;21(4):392-396.

open access

Vol 21, No 4 (2014)
Original articles
Published online: 2014-08-29

Abstract

Background: Obstructive sleep apnea (OSA) has been identified as associated with the onset and propagation of atrial fibrillation (AF) and predicts recurrences of AF after pulmonary vein isolation (PVI). Vice versa, it has never been investigated whether PVI influences OSA. However, it has been controversial whether a restored atrial function can affect the course of OSA. There­fore, we have assessed whether PVI procedure modulates the prevalence and severity of OSA.

Methods and Results: We included 23 individuals with AF that were assigned to undergo PVI into this study. Patients were 65 ± 7 years old, obese (BMI 29.9 ± 5.4 kg/m2), white (100%) and had a normal left ventricular function (LVEF 64 ± 9%). Polygraphic assessment was carried out before and 6 months after PVI. The prevalence of OSA, defined as an apnea-hypopnea index (AHI) ≥ 5 per hour of sleep, was 74% before PVI compared to 70% 6 months after the procedure (p > 0.05). Severity of OSA did not differ (AHI before vs. after: 18 ± 18/h vs. 15 ± 17/h, p > 0.05) as well as further polygraphic parameters did not differ before and after the procedure.

Conclusions: Prevalence and severity of OSA are not affected by PVI in patients suffering from AF.

Abstract

Background: Obstructive sleep apnea (OSA) has been identified as associated with the onset and propagation of atrial fibrillation (AF) and predicts recurrences of AF after pulmonary vein isolation (PVI). Vice versa, it has never been investigated whether PVI influences OSA. However, it has been controversial whether a restored atrial function can affect the course of OSA. There­fore, we have assessed whether PVI procedure modulates the prevalence and severity of OSA.

Methods and Results: We included 23 individuals with AF that were assigned to undergo PVI into this study. Patients were 65 ± 7 years old, obese (BMI 29.9 ± 5.4 kg/m2), white (100%) and had a normal left ventricular function (LVEF 64 ± 9%). Polygraphic assessment was carried out before and 6 months after PVI. The prevalence of OSA, defined as an apnea-hypopnea index (AHI) ≥ 5 per hour of sleep, was 74% before PVI compared to 70% 6 months after the procedure (p > 0.05). Severity of OSA did not differ (AHI before vs. after: 18 ± 18/h vs. 15 ± 17/h, p > 0.05) as well as further polygraphic parameters did not differ before and after the procedure.

Conclusions: Prevalence and severity of OSA are not affected by PVI in patients suffering from AF.

Get Citation

Keywords

obstructive sleep apnea, pulmonary vein isolation, atrial fibrillation

About this article
Title

Impact of pulmonary vein isolation on obstructive sleep apnea in patients with atrial fibrillation

Journal

Cardiology Journal

Issue

Vol 21, No 4 (2014)

Pages

392-396

Published online

2014-08-29

DOI

10.5603/CJ.a2013.0122

Bibliographic record

Cardiol J 2014;21(4):392-396.

Keywords

obstructive sleep apnea
pulmonary vein isolation
atrial fibrillation

Authors

Friedrich Felix Hoyer
Katharina Henrich
Jens Kreuz
Carmen Pizarro
Jan-Wilko Schrickel
Lars Martin Lickfett
Erica Mittmann-Braun
Uwe Juergens
Georg Nickenig
Dirk Skowasch

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl